Literature DB >> 12207643

Is intent-to-treat analysis always (ever) enough?

Lewis B Sheiner1.   

Abstract

Mesh：

Year:  2002        PMID： 12207643      PMCID： PMC1874399          DOI： 10.1046/j.1365-2125.2002.01628.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling in drug development.

Authors:  L B Sheiner; J L Steimer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Population modelling in drug development.

Authors:  L Sheiner; J Wakefield
Journal:  Stat Methods Med Res       Date:  1999-09       Impact factor: 3.021

Review 3.  Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.

Authors:  R J Little; D B Rubin
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

4.  Analysis of clinical trials by treatment actually received: is it really an option?

Authors:  Y J Lee; J H Ellenberg; D G Hirtz; K B Nelson
Journal:  Stat Med       Date:  1991-10       Impact factor: 2.373

5.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

Review 6.  Intention-to-treat analysis and the goals of clinical trials.

Authors:  L B Sheiner; D B Rubin
Journal:  Clin Pharmacol Ther       Date:  1995-01       Impact factor: 6.875

7.  Randomized consent designs for clinical trials: an update.

Authors:  M Zelen
Journal:  Stat Med       Date:  1990-06       Impact factor: 2.373

8.  On estimating efficacy from clinical trials.

Authors:  A Sommer; S L Zeger
Journal:  Stat Med       Date:  1991-01       Impact factor: 2.373

9.  A new design for randomized clinical trials.

Authors:  M Zelen
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

Review 10.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447
  10 in total
  14 in total

1.  Substance-use outcomes at 18 months past baseline: the PROSPER Community-University Partnership Trial.

Authors:  Richard Spoth; Cleve Redmond; Chungyeol Shin; Mark Greenberg; Scott Clair; Mark Feinberg
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

2.  Improving Adherence to Smoking Cessation Treatment: Smoking Outcomes in a Web-based Randomized Trial.

Authors:  Amanda L Graham; George D Papandonatos; Sarah Cha; Bahar Erar; Michael S Amato
Journal:  Ann Behav Med       Date:  2018-03-15

3.  Preventing substance misuse through community-university partnerships: randomized controlled trial outcomes 4½ years past baseline.

Authors:  Richard Spoth; Cleve Redmond; Scott Clair; Chungyeol Shin; Mark Greenberg; Mark Feinberg
Journal:  Am J Prev Med       Date:  2011-04       Impact factor: 5.043

4.  Disease system analysis: basic disease progression models in degenerative disease.

Authors:  Teun M Post; Jan I Freijer; Joost DeJongh; Meindert Danhof
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  Modeling NSCLC progression: recent advances and opportunities available.

Authors:  Ahmed Abbas Suleiman; Lucia Nogova; Uwe Fuhr
Journal:  AAPS J       Date:  2013-02-13       Impact factor: 4.009

6.  Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Authors:  Marco Valgimigli; Hector M Garcia-Garcia; Bernard Vrijens; Pascal Vranckx; Eugène P McFadden; Francesco Costa; Karen Pieper; David M Vock; Min Zhang; Gerrit-Anne Van Es; Pierluigi Tricoci; Usman Baber; Gabriel Steg; Gilles Montalescot; Dominick J Angiolillo; Patrick W Serruys; Andrew Farb; Stephan Windecker; Adnan Kastrati; Antonio Colombo; Fausto Feres; Peter Jüni; Gregg W Stone; Deepak L Bhatt; Roxana Mehran; Jan G P Tijssen
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

7.  Intention-to-treat concept: A review.

Authors:  Sandeep K Gupta
Journal:  Perspect Clin Res       Date:  2011-07

8.  Incremental patient care program decreases anxiety, reduces depression and improves the quality of life in patients with colorectal cancer receiving adjuvant chemotherapy.

Authors:  Jiaying Li; Xuesong Liu
Journal:  Exp Ther Med       Date:  2019-08-13       Impact factor: 2.447

9.  Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.

Authors:  Christian Bianchi; William Tettelbach; Niki Istwan; Brandon Hubbs; Kimberly Kot; Stan Harris; Donald Fetterolf
Journal:  Int Wound J       Date:  2019-03-12       Impact factor: 3.315

10.  Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?

Authors:  Renatus Ziegler
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-04       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.